EL SINDROME UREMICO HEMOLITICO Y MANEJO RENAL DE PROTEINAS

(especial para SIIC © Derechos reservados)
La fisiopatología de este síndrome es más compleja de lo que se creía ya que la alteración tubular desarrollada conlleva fallas en el mecanismo de endocitosis de proteínas, las cuales se suman a las eliminadas por las alteraciones a nivel de la barrera de filtración.
Autor:
Federico Ochoa
Columnista Experta de SIIC

Institución:
Universidad de Buenos Aires


Artículos publicados por Federico Ochoa
Coautores
Abril Seyahian* Elsa Zotta** 
Farmacéutica, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina*
Médica, Universidad de Buenos Aires, Buenos Aires, Argentina**
Recepción del artículo
25 de Julio, 2017
Aprobación
15 de Mayo, 2018
Primera edición
21 de Mayo, 2018
Segunda edición, ampliada y corregida
6 de Agosto, 2024

Resumen
El síndrome urémico hemolítico (SUH) está definido por la tríada de anemia hemolítica microangiopática, trombocitopenia e insuficiencia renal aguda. En Argentina constituye la primera causa de insuficiencia renal aguda en pediatría. Aproximadamente, del 2% al 4% de los pacientes mueren durante la fase aguda de la enfermedad, y solo un tercio del 96% restante que sobrevive lo hace con secuelas renales, como la persistencia de la proteinuria. Un individuo adulto sano filtra alrededor de 5000 mg/día de proteínas, si bien la excreción en orina es escasa (150 mg/día). La escasa cantidad de proteínas excretadas indica la presencia de un mecanismo de reabsorción a nivel del túbulo proximal. Por lo tanto, la reabsorción tubular renal desempeña un papel muy importante ya que, ante una función glomerular normal, es el principal mecanismo encargado de evitar la depleción proteica corporal. Desde hace aproximadamente 30 años se sabe que la albúmina es reabsorbida en el túbulo proximal. La reabsorción proteica se produce por un mecanismo de endocitosis mediada por el receptor dependiente de clatrina y por endocitosis de fase líquida. Clásicamente se ha descrito que el mecanismo básico del daño renal en el SUH típico y en el atípico es una microangiopatía trombótica, pero de diferentes causas. Sin embargo, debe tenerse en cuenta que la fisiopatología de esta enfermedad es más compleja de lo que se creía, ya que la alteración tubular que surge va a evolucionar en fallas en el mecanismo de endocitosis de proteínas que se suman a las eliminadas por las alteraciones a nivel de la barrera de filtración glomerular.

Palabras clave
proteinuria, megalina, cubilina, FCRN, podocito, endocitosis, diafragma de filtración, síndrome urémico hemólitico, SUH atípico, insuficiencia renal


Artículo completo

(castellano)
Extensión:  +/-4.99 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Hemolytic uremic syndrome (HUS) is defined by the triad of hemolytic anemia microangiopathic, thrombocytopenia and acute renal failure. In Argentina it constitutes the first cause of acute renal failure in Pediatrics. Approximately 2-4% of patients die during the acute phase of the disease, and only a third of the remaining 96% survive with renal sequelae, such as the persistence of proteinuria.
A healthy adult filters around 5000 mg/day of proteins, with an excretion in urine of 150 mg/day. The little quantity of proteins excreted indicates the presence of a reabsorption mechanism at the level of the proximal tubule. Therefore, the tubular reabsorption plays a very important role since it is the main mechanism responsible for preventing the depletion of protein.
For approximately 30 years, it has been known that albumin is reabsorbed in the proximal tubule. Protein reabsorption occurs by a clathrin-dependent receptor mediated endocytosis mechanism and by fluid phase endocytosis. The basic mechanism of renal damage in typical and atypical HUS has been described as a thrombotic microangiopathy, but of different causes. However, the pathophysiology of this disease is more complex than what was believed since the emerging tubular alteration will ewvolve into failures of the protein endocytosis mechanism that are added to the alterations at the level of the glomerular filtration barrier.

Key words
proteinuria, megalin, cubilin, FCRN, podocyte, endocytosis, slit diaphragm, hemolytic uremic syndrome, atypic hus, renal failure


Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Anatomía Patológica, Nefrología y Medio Interno
Relacionadas: Pediatría, Trasplantes



Comprar este artículo
Extensión: 4.99 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Elsa Zotta, 1121, Paraguay 2155, Buenos Aires, Argentina
Bibliografía del artículo
1. Rivero MA, et al. Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina. Medicina (Buenos Aires) 64(4):352-356, 2004.
2. Ibarra C, et al. Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli. Arch Argent Pediatr 106(5):435-442, 2008.
3. Repetto HA. Epidemic hemolytic-uremic syndrome in children. Kidney Int 52(6):1708-1719, 1997.
4. Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol 2(4):205-210, 1994.
5. Monteverde ML. Síndrome Urémico hemolítico. Nefrología, diálisis y trasplante 34(1):27-41, 2014.
6. Giebisch GW. Organization of the Urinary System. En: Medical Physiology, W. Boron (Ed.). Elsevier Science; 2003. Pp. 737-755.
7. Ganong W. Review of Medical Physiology. 22ed. New York: McGraw-Hill Medical; 2005.
8. Bhattacharya AA, Grune T, Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303(5):721-732, 2000.
9. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 33(1):17-53, 1981.
10. Michael AF, Blau E, Vernier RL. Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest 23(6):649-657, 1970.
11. Valtin HS. Renal function. 3rd ed. Boston: Little, Brown and Company; 1996.
12. Ulate G. Fisiología renal. San José: Editorial de la Universidad de Costa Rica; 2006.
13. Tryggvason K, Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med 254(3):216-224, 2003.
14. Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med 133(2):201-216, 2009.
15. Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 60(2):423-433, 1974.
16. Kestila M, et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell 1(4):575-582, 1998.
17. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 15(6):1382-1391, 2004.
18. Yuan H, Takeuchi E, Salant DJ. Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol Renal Physiol 282(4):F585-591, 2002.
19. Kershaw DB, et al. Molecular cloning, expression, and characterization of podocalyxin-like protein 1 from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J Biol Chem 270(49):29439-29446, 1995.
20. Kerjaschki D, Sharkey DJ, Farquhar MG. Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98(4):1591-1596, 1984.
21. Jerums G, et al. Why is proteinuria such an important risk factor for progression in clinical trials? Kidney Int Suppl 63:S87-92, 1997.
22. Zotta E, et al. Development of an experimental hemolytic uremic syndrome in rats. Pediatr Nephrol 23(4):559-567, 2008.
23. Park CH, Maack T. Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 73(3):767-777, 1984.
24. Birn H, et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 105(10):1353-1361, 2000.
25. Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280(4):F562-573, 2001.
26. Russo LM, et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71(6):504-513, 2007.
27. Sandoval RM, et al. Multiple factors influence glomerular albumin permeability in rats. J Am Soc Nephrol 23(3):447-457, 2012.
28. Dickson LE, et al. The proximal tubule and albuminuria: really! J Am Soc Nephrol 25(3):443-453, 2014.
29. Tenten V, et al. Albumin is recycled from the primary urine by tubular transcytosis. J Am Soc Nephrol 24(12):1966-1980, 2013.
30. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3(4):256-266, 2002.
31. Clapp WL, et al. Axial heterogeneity in the handling of albumin by the rabbit proximal tubule. Lab Invest 58(5):549-558, 1988.
32. Mansson LE, et al. Progression of bacterial infections studied in real time--novel perspectives provided by multiphoton microscopy. Cell Microbiol 9(10):2334-2343, 2007.
33. Melican K, et al. Bacterial infection-mediated mucosal signalling induces local renal ischaemia as a defence against sepsis. Cell Microbiol 10(10):1987-1998, 2008.
34. Wall DA, Maack T. Endocytic uptake, transport, and catabolism of proteins by epithelial cells. Am J Physiol 248(1):C12-20, 1985.
35. Maack T, et al. Atrial natriuretic factor: structure and functional properties. Kidney Int 27(4):607-615, 1985.
36. Haymann JP, et al. Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 11(4):632-639, 2000.
37. Sarav M, et al. Renal FcRn reclaims albumin but facilitates elimination of IgG. J Am Soc Nephrol 20(9):1941-1952, 2009.
38. Andersen JT, et al. Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. J Biol Chem 285(7):4826-4836, 2010.
39. Simister NE, Rees AR. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol 15(7):733-738, 1985.
40. Chaudhury C, et al. Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry 45(15):4983-4990, 2006.
41. Greive KA, et al. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am J Pathol 159(3):1159-1170, 2001.
42. Hilliard LM, et al. Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney. J Lab Clin Med 147(1):36-44, 2006.
43. Koltun M, et al. Mechanism of hypoalbuminemia in rodents. Am J Physiol Heart Circ Physiol 288(4):H1604-1610, 2005.
44. Eppel GA, et al. The return of glomerular-filtered albumin to the rat renal vein. Kidney Int 55(5):1861-1870, 1999.
45. Koltun M, Comper WD. Retention of albumin in the circulation is governed by saturable renal cell-mediated processes. Microcirculation 11(4):351-360, 2004.
46. Christensen EI, et al. Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. Eur J Cell Biol 66(4):349-364, 1995.
47. Russo LM, et al. Renal processing of albumin in diabetes and hypertension in rats: possible role of TGF-beta1. Am J Nephrol 23(2):61-70, 2003.
48. Creydt VP, et al. Cytotoxic effect of Shiga toxin type 2 and its B subunit on human renal tubular epithelial cell cultures. Medicina (Buenos Aires) 65(2):147-150, 2005.
49. Ochoa F, et al. Characterization of stx2 tubular response in a rat experimental model of hemolytic uremic syndrome. Am J Nephrol 32(4):340-346, 2010.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008